Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26607
Title: | Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature. | Austin Authors: | Bar, Claire;Barcia, Giulia;Jennesson, Mélanie;Le Guyader, Gwenaël;Schneider, Amy L ;Mignot, Cyril;Lesca, Gaetan;Breuillard, Delphine;Montomoli, Martino;Keren, Boris;Doummar, Diane;Billette de Villemeur, Thierry;Afenjar, Alexandra;Marey, Isabelle;Gerard, Marion;Isnard, Hervé;Poisson, Alice;Dupont, Sophie;Berquin, Patrick;Meyer, Pierre;Genevieve, David;De Saint Martin, Anne;El Chehadeh, Salima;Chelly, Jamel;Guët, Agnès;Scalais, Emmanuel;Dorison, Nathalie;Myers, Candace T;Mefford, Heather C;Howell, Katherine B;Marini, Carla;Freeman, Jeremy L;Nica, Anca;Terrone, Gaetano;Sekhara, Tayeb;Lebre, Anne-Sophie;Odent, Sylvie;Sadleir, Lynette G;Munnich, Arnold;Guerrini, Renzo;Scheffer, Ingrid E ;Kabashi, Edor;Nabbout, Rima | Affiliation: | Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Hôpital Necker-Enfants Malades, Paris, France Neurosciences centre of Lyon, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Bron Cedex, France Département de Génétique et de Cytogénétique, Centre de Reference Déficience Intellectuelle de Causes Rares, APHP, Hôpital Pitié-Salpêtrière, GRC UPMC (Déficience Intellectuelle et Autisme), Paris, France EA3808-NEUVACOD Unité Neurovasculaire et Troubles Cognitifs, Pôle Biologie Santé, Université de Poitiers, Poitiers, France Department of Translational Medical Sciences, Section of Pediatrics-Child Neurology Unit, Federico II University, Naples, Italy Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Department of Neuroscience, A Meyer Children's Hospital, University of Florence, Florence, Italy Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand The Florey Institute of Neuroscience and Mental Health Epilepsy Research Centre Murdoch Children's Research Institute, Melbourne, Victoria, Australia Departments of Neurology and Paediatrics, Royal Children's Hospital, University of Melbourne, Melbourne, Victoria, Australia Department of genetics, University hospital Poitiers, Poitiers Cedex, France Department of genetics, Hospices Civils de Lyon, Lyon, France Epileptology and Rehabilitation department, GH Pitie-Salpêtrière-Charles Foix, AP-HP, Paris, France Institut du Cerveau et de la Moelle épinière, INSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Paris, France PhyMedExp, U1046 INSERM, UMR9214 CNRS, Montpellier, France Department of pediatric neurology, Montpellier university hospital, Montpellier, France Institute of genetics and development, CNRS UMR 6290, Rennes university, Rennes, France Reference Centre for Rare Developmental Abnormalities, CLAD-Ouest, CHU Rennes, Rennes, France Department of genetics, Necker Enfants Malades hospital, Assistance Publique-Hôpitaux de Paris, Paris, France Université Paris Descartes-Sorbonne Paris Cité, Paris, France Imagine institute, laboratory of Translational Research for Neurological Disorders, INSERM UMR 1163, Imagine Institute, Paris, France Department of Pediatrics, American Memorial Hospital, Reims, France Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Hôpital Necker-Enfants Malades, Paris, France Département de Génétique et de Cytogénétique, Centre de Reference Déficience Intellectuelle de Causes Rares, APHP, Hôpital Pitié-Salpêtrière, GRC UPMC (Déficience Intellectuelle et Autisme), Paris, France Department of Pediatric Neurology, Hôpital Armand Trousseau, AP-HP, Paris, France Département de Génétique et Embryologie Médicale, Pathologies Congénitales du Cervelet-LeucoDystrophies, Centre de Référence déficiences intellectuelles de causes rares, AP-HP, Hôpital Armand Trousseau, GRC n°19, Sorbonne Université, Paris, France Département de Génétique et de Cytogénétique, Centre de Reference Déficience Intellectuelle de Causes Rares, APHP, Hôpital Pitié-Salpêtrière, GRC UPMC (Déficience Intellectuelle et Autisme), Paris, France Department of genetics, CHU Côte de Nacre, Caen, France Neurology clinic, Lyon, France Reference Center for Diagnosis and Management of Genetic Psychiatric Disorders, Centre Hospitalier le Vinatier and EDR-Psy Team, Centre National de la Recherche Scientifique & Lyon 1 Claude Bernard University, Villeurbanne, France Department of pediatric neurology Amiens-Picardie university hospital, Université de Picardie Jules Verne, Amiens, France Service de génétique clinique et du Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de référence maladies rares anomalies du développement, CHU Montpellier, Montpellier, France Department of Pediatric Neurology, Strasbourg University Hospital, Strasbourg, France Department of genetics, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France Department of Pediatric, Louis-Mourier Hospital, Colombes, France Department of Pediatric Neurology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg City, Luxembourg Department of pediatric Neurosurgery, Rothschild Foundation Hospital, Paris, France Department of Pediatrics, University of Washington, Seattle, Washington Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington Department of Neurology, Center for Clinical Research (CIC 1414), Rennes University Hospital, Rennes, France Department of Pediatric Neurology, C.H.I.R.E.C, Brussels, Belgium Department of genetics, Maison Blanche hospital, University hospital, Reims, Reims, France |
Issue Date: | Jan-2020 | metadata.dc.date: | 2019-10-04 | Publication information: | Human Mutation 2020; 41(1): 69-80 | Abstract: | Developmental and epileptic encephalopathies (DEE) refer to a heterogeneous group of devastating neurodevelopmental disorders. Variants in KCNB1 have been recently reported in patients with early-onset DEE. KCNB1 encodes the α subunit of the delayed rectifier voltage-dependent potassium channel Kv 2.1. We review the 37 previously reported patients carrying 29 distinct KCNB1 variants and significantly expand the mutational spectrum describing 18 novel variants from 27 unreported patients. Most variants occur de novo and mainly consist of missense variants located on the voltage sensor and the pore domain of Kv 2.1. We also report the first inherited variant (p.Arg583*). KCNB1-related encephalopathies encompass a wide spectrum of neurodevelopmental disorders with predominant language difficulties and behavioral impairment. Eighty-five percent of patients developed epilepsies with variable syndromes and prognosis. Truncating variants in the C-terminal domain are associated with a less-severe epileptic phenotype. Overall, this report provides an up-to-date review of the mutational and clinical spectrum of KCNB1, strengthening its place as a causal gene in DEEs and emphasizing the need for further functional studies to unravel the underlying mechanisms. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26607 | DOI: | 10.1002/humu.23915 | ORCID: | 0000-0003-1489-0211 0000-0001-5877-4074 |
Journal: | Human Mutation | PubMed URL: | 31513310 | Type: | Journal Article | Subjects: | KCNB1 developmental and epileptic encephalopathy epilepsy potassium channel |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.